J&J says Covid-19 booster shots gives good immunological response
Johnson & Johnson said on Wednesday that the second doseof its Covid-19 vaccine had a positive immunological response in early-stageclinical trials for people previously vaccinated with the single dose
By
Published - Aug 25, 2021, 06:01 PM ET
Last Updated - Jun 05, 2024, 01:05 AM EDT
By Ishika Dangayach, 11:00 AM ET
Johnson & Johnson said on Wednesday that the second doseof its Covid-19 vaccine had a positive immunological response in early-stageclinical trials for people previously vaccinated with the single dose.
The Centers for Disease Control and Prevention has said thatsingle-dose J&J vaccination recipients would require boosters but has notmade any recommendations in the absence of further evidence.
The findings announced on Wednesday are likely to guide theUnited States' booster approach, which is slated to begin in September, whenthe country expects to begin giving boosters to those who got messenger-RNAvaccinations, WSJ reported.
